All the news

NeOn project: UniSR in the research consortium led by Dompé

17 December 2020
Research

Developing a platform dedicated to the research and development of new drugs for the treatment of degenerative diseases of the central nervous system, such as Alzheimer's, and oncology: this is the goal of the NeOn Project, which started after the agreement signed in Milan at the Dompé headquarters.

The biopharmaceutical company is the leader of a real "scientific consortium" that brings together organizations and companies among the highest levels of excellence in their respective areas of expertise. Among these, the Vita-Salute San Raffaele University, together with the University and Polytechnic of Milan, the European Institute of Oncology, the CNR Institute of Neuroscience, the Italian Institute of Technology, and the companies Proxentia srl ​​and Neuro-zone srl.

A virtuous example of how public and private come together to create excellence, for the local area and for patients”, said Sergio Dompé, President and CEO of Dompé Pharmaceuticals. "With 28 thousand employees in the sector, the Lombardy Region is the hub of the activity of centers of excellence recognized worldwide with which we will work to identify new therapeutic solutions".

The participation of the Vita-Salute San Raffaele University will involve numerous researchers who study the molecular mechanisms of neuronal degeneration in order to identify neuroprotective and neuroregenerative strategies.

"Our University, in addition to providing an essential scientific contribution, has had and continues to play a key role in coordinating, together with the lead partner Dompé, all management aspects ranging from project investigation to reporting activities"

states Dr. Daniele Zacchetti, project operational coordinator on behalf of the Vita-Salute San Raffaele University and senior researcher at the IRCCS San Raffaele Hospital.

The project therefore aims to be a virtuous example of public-private collaboration which, by pooling their respective skills, can generate an innovative research and development model that is significant in terms of scientific results that can be used and developed in the future by the same companies participating in the project or even from other future partners.

NeOn is created with the contribution of resources from the European Union, the Italian State and the Lombardy Region and co-financed with the European Regional Development Fund 2014-2020 resources.

Share news

You might be interested in

Boletta and Iannacone awarded two ERC Advanced Grants
Awards11 April 2024
Boletta and Iannacone awarded two ERC Advanced Grants
Demonstrated efficacy of a new CAR-Treg therapy in a model of systemic lupus erythematosus
Research27 March 2024
Demonstrated efficacy of a new CAR-Treg therapy in a model of systemic lupus erythematosus
T lymphocytes are sufficient to protect from COVID-19 even in the absence of antibodies
Research14 March 2024
T lymphocytes are sufficient to protect from COVID-19 even in the absence of antibodies
ERC Consolidator Grant awarded to Dr. Donato Inverso
Awards08 March 2024
ERC Consolidator Grant awarded to Dr. Donato Inverso